Home » About » Newsletters

Newsletters

This page contains an archive of our research area specific eNewsletters. If you would like to be kept up to date on new products, promotions, and up and coming events, sign up to receive Novus eNews. Create a new account here, or if you already have an account, login and click on Profile.

FoxA1/HNF-3 alpha Monoclonal Antibodies

Novus has recently launched two new monoclonal antibodies against HNF-3 alpha/FoxA1 (NBP2-45354 and NBP2-45269), a transcription factor that is implicated in the development and progression of breast and prostate cancer. These antibodies have been validated in WB, Flow, ICC/IF and IHC-P applications and are available in 17 pre-conjugated formats as well as

Cancer Immunology

Save 20% on Inhibitors

Inhibitory receptor ligand expressed on the tumor cell surface can limit a T cell response. Blocking the interaction between the inhibitory receptor and its ligand can promote T cell immunity and tumor destruction. Novus Biologicals offers high-quality, IHC validated antibodies to help you understand tumor morphology and inhibitory receptor/ligand expression.

...

Novus Conjugated Antibodies
Novus Conjugated Antibodies

Using a conjugated primary antibody reduces both the complexity of experimental design and the required hands-on time during an experimental run. Novus Biologicals offers a complete conjugation solution to ensure you get the primary antibody you need, labeled with the conjugate you want. Our Antibody Lab will conjugate as little as 1 vial and as much as your experiment requires. We can help you pick your conjugate and stay within your budget. In addition to our conjugated antibodies, Lightning-Link™ Antibody Labeling Kits by Novus empower you to conjugate nearly any antibody in your own lab to over 40...

New mAbs to GLUT4 (clones 6H11NB and 2E11NB)

Glucose Transporter GLUT4 (SLC2A4) is an insulin-sensitive glucose transporter which facilitates glucose uptake in insulin-responsive tissues such as adipose tissue, skeletal muscle and cardiac tissues. GLUT4 involves in Warburg Effect, Insulin Receptor and AMPK signaling pathways, and defective GLUT4 has been suggested to be one of the underlying causes of type-2 diabetes.

Novus Biologicals has recently launched two new mouse monoclonal antibodies/mAbs to GLUT4 (

Novel mAbs to HLA DMA (clones 5C9NB and 6B12NB)

HLA-DMA belongs to the HLA class II alpha chain paralogues and it is found mainly on the cell surface, late endosomal/lysosomal membranes and the multivesicular bodies of antigen presentation cells/APCs. Along with its inhibitor HLA-DO, it controls the endosomal generation of peptide- MHC-II complexes which then traffic to the cell surface ultimately regulating antigen presentation via selection and activation of CD4+ T cells.

HLA-DMA is an emerging target in basic and clinical immunology, and Novus Biologicals has recently launched two novel mouse monoclonal antibodies/mAbs to HLA DMA (NBP2-44300/clone 5C9NB and...

Pages